Dubin Steve

DirectorAdicet Bio, Inc. (ACET) · full profile →Form 4 · filed Aug 23, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
8
0 non-derivative · 8 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 21, 2024Grant(A)19K$019K
Aug 21, 2024Disposed to issuer(D)19K$00
Aug 21, 2024Grant(A)19K$019K
Aug 21, 2024Grant(A)30K$030K
Aug 21, 2024Disposed to issuer(D)30K$00
Aug 21, 2024Grant(A)26K$026K
Aug 21, 2024Disposed to issuer(D)26K$00
Aug 21, 2024Disposed to issuer(D)19K$00

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-100174) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about ACET insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0000950170-24-100174"
Ask your agent
Use Arkolith to summarize insider buying and selling at Adicet Bio, Inc.
over the last 90 days and cite the filings.